European Pharmaceutical Review

APRIL 3, 2023

The committee recommended granting a paediatric-use marketing authorisation (PUMA) for Pedmarqsi (sodium thiosulfate) for preventing ototoxicity induced by cisplatin chemotherapy. Ototoxicity is the development of hearing or balance problems due to a medicine. Cisplatin is a chemotherapy used to treat several types of cancer.

Vaccines 82

Vaccines Chemotherapy Generic Medicine Biosimilars 82

European Pharmaceutical Review

JANUARY 30, 2024

Ryzneuta (efbemalenograstim alfa) received a positive opinion from the CHMP as a medicine to reduce the duration of neutropenia and the incidence of febrile neutropenia due to chemotherapy. Additionally, a positive opinion for Niapelf (paliperidone), a generic medicine for schizophrenia was adopted in the meeting.

Generic Medicine 95

Generic Medicine Chemotherapy Hospitals 95

Quality Matters

MAY 22, 2023

Identifying upstream supply chain vulnerabilities can help mitigate or prevent drug shortages After Laura Bray’s daughter was diagnosed with cancer and began chemotherapy treatment, she faced three separate shortages of the life-saving drugs she needed, all within nine months. kristine.gates… Mon, 05/22/2023 - 10:48 Supply Chain

Generic Medicine 52

Generic Medicine Chemotherapy 52

Quality Matters

OCTOBER 24, 2023

Some hospitals have reported rationing doses in response to these shortages, and the American Society of Clinical Oncologists (ASCO) has issued new clinical guidance for treating patients with gastrointestinal (GI) cancers, which are commonly treated with carboplatin and cisplatin, two chemotherapy agents currently in shortage nationwide.

Hospitals 52

Hospitals Generic Medicine Chemotherapy 52